4.5 Article

In vitro antitumor immune response induced by dendritic cells transduced with human livin α recombinant adenovirus

Journal

CELLULAR IMMUNOLOGY
Volume 297, Issue 1, Pages 46-52

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2015.06.003

Keywords

Livin alpha; Recombinant adenoviral vector; Gene therapy; Dendritic cell; Tumor cell

Funding

  1. Project of Natural Science Foundation of China [81160294]
  2. Science and Technology Research Program of Jiangxi Provincial Education Department [GJJ13161]
  3. Key Project of Science and Technology Research Foundation of Hubei Province [2007JX3A05]

Ask authors/readers for more resources

Transduction with recombinant, replication-defective adenoviral (rAd) vectors encoding a transgene is an efficient method for gene transfer into human dendritic cells (DCs). Livin is a good candidate for cancer immunotherapy since it is overexpressed in most common human cancers, poorly expressed in most normal adult tissues. Two splicing variants of livin, designated livin alpha and livin beta, have been identified. In this study, we used human livin a recombinant adenovirus (rAd-hlivin alpha) to transduced DCs. We found that DCs transduced with rAd-hlivin alpha (rAd-hlivin alpha DCs) could effectively induce human livin alpha specific cytotoxic T lymphocytes (CTL) in vitro against various tumor cell lines. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available